News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
662,161 Results
Type
Article (52060)
Company Profile (125)
Press Release (609967)
Multimedia
Podcasts (105)
Webinars (20)
Section
Business (175812)
Career Advice (2529)
Deals (31516)
Drug Delivery (135)
Drug Development (78036)
Employer Resources (147)
FDA (16265)
Job Trends (14129)
News (309458)
Policy (31274)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (2)
Academia (2813)
Academic (1)
Accelerated approval (50)
Adcomms (34)
Allergies (180)
Alliances (44706)
ALS (217)
Alzheimer's disease (1865)
Antibody-drug conjugate (ADC) (474)
Approvals (16631)
Artificial intelligence (682)
Autoimmune disease (306)
Automation (53)
Bankruptcy (343)
Best Places to Work (11030)
BIOSECURE Act (16)
Biosimilars (213)
Biotechnology (83)
Bladder cancer (201)
Brain cancer (74)
Breast cancer (771)
Cancer (5953)
Cardiovascular disease (501)
Career advice (2157)
Career pathing (47)
CAR-T (327)
CDC (61)
Celiac Disease (3)
Cell therapy (903)
Cervical cancer (49)
Clinical research (68114)
Collaboration (1980)
Company closure (6)
Compensation (822)
Complete response letters (89)
COVID-19 (2774)
CRISPR (102)
C-suite (1198)
Cystic fibrosis (132)
Data (8044)
Decentralized trials (3)
Denatured (32)
Depression (181)
Dermatology (92)
Diabetes (605)
Diagnostics (6771)
Digital health (55)
Diversity (10)
Diversity, equity & inclusion (39)
Drug discovery (303)
Drug pricing (206)
Drug shortages (33)
Duchenne muscular dystrophy (293)
Earnings (69362)
Editorial (69)
Employer branding (19)
Employer resources (138)
Events (96517)
Executive appointments (1134)
FDA (20040)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (17)
Frontotemporal dementia (34)
Funding (1651)
Gene editing (229)
Generative AI (60)
Gene therapy (744)
GLP-1 (1115)
Government (4876)
Grass and pollen (7)
Guidances (412)
Healthcare (18469)
HIV (83)
Huntington's disease (56)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (103)
Immunology and inflammation (313)
Immuno-oncology (96)
Indications (195)
Infectious disease (3131)
Inflammatory bowel disease (219)
Inflation Reduction Act (13)
Influenza (136)
Intellectual property (289)
Interviews (535)
IPO (14131)
IRA (53)
Job creations (3395)
Job search strategy (1738)
JPM (61)
Kidney cancer (21)
Labor market (79)
Layoffs (557)
Leadership (49)
Legal (6977)
Liver cancer (105)
Longevity (29)
Lung cancer (803)
Lymphoma (426)
Machine learning (53)
Management (52)
Manufacturing (972)
MASH (218)
Medical device (14625)
Medtech (14757)
Mergers & acquisitions (18556)
Metabolic disorders (1590)
mRNA (213)
Multiple sclerosis (193)
NASH (24)
Neurodegenerative disease (446)
Neuropsychiatric disorders (118)
Neuroscience (3442)
Neurotech (1)
NextGen: Class of 2026 (6398)
Non-profit (4525)
Now hiring (70)
Obesity (728)
Opinion (315)
Ovarian cancer (228)
Pain (260)
Pancreatic cancer (312)
Parkinson's disease (371)
Partnered (33)
Patents (592)
Patient recruitment (698)
Peanut (63)
People (58659)
Pharmaceutical (27)
Pharmacy benefit managers (26)
Phase 1 (21006)
Phase 2 (29901)
Phase 3 (22715)
Pipeline (8914)
Policy (333)
Postmarket research (2554)
Preclinical (8696)
Press Release (59)
Prostate cancer (313)
Psychedelics (62)
Radiopharmaceuticals (320)
Rare diseases (1101)
Real estate (5181)
Recruiting (64)
Regulatory (24927)
Reports (34)
Research institute (2474)
Resumes & cover letters (364)
Rett syndrome (39)
RNA editing (23)
RSV (83)
Schizophrenia (189)
Series A (273)
Series B (204)
Service/supplier (4)
Sickle cell disease (115)
Special edition (24)
Spinal muscular atrophy (178)
Sponsored (46)
Startups (3381)
State (2)
Stomach cancer (20)
Supply chain (121)
Tariffs (81)
The Weekly (71)
Vaccines (1106)
Venture capital (107)
Weight loss (496)
Women's health (115)
Worklife (21)
Date
Today (159)
Last 7 days (561)
Last 30 days (3300)
Last 365 days (28466)
2026 (12577)
2025 (28489)
2024 (33118)
2023 (37452)
2022 (48379)
2021 (52368)
2020 (51381)
2019 (45019)
2018 (34221)
2017 (30733)
2016 (29791)
2015 (34762)
2014 (27061)
2013 (22741)
2012 (24294)
2011 (25060)
2010 (22998)
Location
Africa (842)
Alabama (91)
Alaska (5)
Arizona (310)
Arkansas (15)
Asia (40570)
Australia (7799)
California (11910)
Canada (3650)
China (1382)
Colorado (539)
Connecticut (538)
Delaware (399)
Europe (90100)
Florida (1924)
Georgia (414)
Hawaii (1)
Idaho (63)
Illinois (1043)
India (84)
Indiana (598)
Iowa (21)
Japan (532)
Kansas (132)
Kentucky (44)
Louisiana (44)
Maine (70)
Maryland (1539)
Massachusetts (8291)
Michigan (370)
Minnesota (675)
Mississippi (7)
Missouri (144)
Montana (31)
Nebraska (27)
Nevada (141)
New Hampshire (88)
New Jersey (3370)
New Mexico (24)
New York (3176)
North Carolina (1520)
North Dakota (10)
Northern California (5891)
Ohio (383)
Oklahoma (17)
Oregon (39)
Pennsylvania (2503)
Puerto Rico (28)
Rhode Island (47)
South America (1135)
South Carolina (85)
South Dakota (2)
Southern California (4794)
Tennessee (205)
Texas (2044)
United States (43138)
Utah (390)
Vermont (1)
Virginia (309)
Washington D.C. (79)
Washington State (1006)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
662,161 Results for "regentys formerly known as asana medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Regentis Biomaterials Reports 2025 Financial Results and Provides Business Update
February 25, 2026
·
9 min read
Press Releases
Regentis Implements Strategy for Commercial Deployment of GelrinC(R) in Europe Through Collaboration with Humanitas Hospital and Leading Cartilage Repair Expert Prof. Elizaveta Kon
April 16, 2026
·
9 min read
Press Releases
Regentis Biomaterials Appoints Dr. Galit Reske as Chief Medical Officer: Brings Strong Track Record of Success in Cartilage Repair
February 19, 2026
·
7 min read
Press Releases
Regentis Expands its European Clinical Site Network to Support its Commercial and Clinical Programs
February 17, 2026
·
7 min read
Press Releases
Regentis Biomaterials Develops and Patents New Solvent-Free Manufacturing Process That Increases GelrinC Production Yield by 400%
March 17, 2026
·
5 min read
Press Releases
Regentis Expanding Pivotal Phase III GelrinC Clinical Site Network: Adding Several Leading Orthopedic Centers Across the U.S.
January 29, 2026
·
7 min read
Press Releases
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 8, 2025
·
4 min read
Press Releases
Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering
December 4, 2025
·
4 min read
Press Releases
Regentis’ GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation
January 6, 2026
·
7 min read
Press Releases
Regentis’ GelrinC Demonstrates Breakthrough in Regenerating Native-Like Cartilage Structure in Knee Repair on MRI Results Confirmed Using a Validated, Regulator-Accepted Method
January 20, 2026
·
7 min read
1 of 66,217
Next
